http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1418938-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f600d1296c13d2e86af0e53efe367729 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
| filingDate | 2002-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d385f1fe9111ba70a82724504c8388eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b863c38b03192c8976ba0898bbcf67be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27b861b282819a0ece59f7eb32d22f22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18398b1784f9b15e950de51cd1c35b46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85403afe628246aea72994fa3628e8ac |
| publicationDate | 2004-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1418938-A1 |
| titleOfInvention | Bont/e or snap-25e for treating botulinum toxin a or c1 poisoning and inhibiting muscle contraction |
| abstract | A method for treating a patient with Botulinum toxin A (BoNT/A) or Botulinum toxin C1 (BoNT/C1) poisoning, wherein the patient is administered Botulinum toxin E (BoNT/E) or a polynucleotide encoding and capable of expressing BoNT/E, or a fragment derivable by cleavage of synaptosomal-associated polypeptide of 25 kDa (SNAP-25) or a variant thereof by BoNT/E (SNAP-25E) or a polynucleotide encoding and capable of expressing SNAP-25E. The patient may have botulism acquired naturally or accidentally, or may have been injected with BoNT/A or BoNT/C1 for medical purposes. A method for treating a patient in need of short duration inhibition of exocytosis in a cell of the patient, wherein the patient is administered BoNT/E or a polynucleotide encoding and capable of expressing BoNT/E, or a fragment derivable by cleavage of synaptosomal-associated polypeptide of 25 kDa (SNAP-25) or a variant thereof by BoNT/E (SNAP-25E) or a polynucleotide encoding and capable of expressing SNAP-25E and is not administered BoNT/A, B, C, F or G. The patient may be in need of inhibition of exocytosis of less than 14 days' duration. |
| priorityDate | 2001-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 253.